---
$id: https://graph.org.ai/services/commodity/85445603
$type: Service
source: UNSPSC
code: "85445603"
title: "The diagnosis of ganglionic blocking drugs"
class: "85445600"
classTitle: "Diagnoses of drugs primarily affecting the autonomic nervous system"
family: "85440000"
familyTitle: "Diagnoses of external causes of morbidity and mortality"
segment: "85000000"
segmentTitle: "Healthcare Services"


---

# The diagnosis of ganglionic blocking drugs

**UNSPSC Code**: 85445603
**Class**: [Diagnoses of drugs primarily affecting the autonomic nervous system](Diagnoses of drugs primarily affecting the autonomic nervous system.mdx)
**Family**: [Diagnoses of external causes of morbidity and mortality](../Diagnoses of external causes of morbidity and mortality.mdx)
**Segment**: [Healthcare Services](../../Healthcare Services.mdx)

In this classification, this covers the group of activities that yields a diagnosis of ganglionic blocking drugs, not elsewhere classified. Ganglionic blocking drugs, not elsewhere classified is listed In The World Health Organization's International Statistical Classification of Diseases and Related Health Problems (ICD-10) as a four-character category under code Y51.2.

